Eurand N.V. (Eurand), formerly known as Eurand B.V., is a specialty pharmaceutical company. The Company develops, manufactures and commercializes pharmaceutical and biopharmaceutical products based on its drug formulation technologies. Through its collaboration arrangements, Eurand has applied its technologies to drug products in a range of therapeutic areas, including cardiovascular, gastrointestinal, pain, nutrition and respiratory. It develops and commercializes its own portfolio of products to address cystic fibrosis and gastrointestinal disorders. Eurand is an established business with manufacturing and research facilities in the United States, Italy and France. It manufactures and supplies over 40 different products for sale in pharmaceutical markets.